Gortner L, Misselwitz B (2011) Rates of bronchopulmonary dysplasia in very preterm neonates in Europe: results from the MOSAIC cohort. Neonatology 99:112–117. doi:10.1159/000313024
Article
PubMed
Google Scholar
Islam JA, Keller RL, Aschner JL, Hartert TV, Moore PE et al (2015) Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia. Am J Respir Crit Care Med 192(2):134–156. doi:10.1164/rccm.201412-2142PP
Article
PubMed
Google Scholar
Didon L, Roos AB, Elmberger GP, Gonzalez FJ, Nord M et al (2010) Lung-specific inactivation of CCAAT/enhancer binding protein a causes a pathological pattern characteristic of COPD. Eur Respir J 35(1):186–197. doi:10.1183/09031936.00185008
Article
CAS
PubMed
Google Scholar
Carraro S, Giordano G, Pirillo P, Maretti M, Reniero F, Cogo PE, Perilongo G, Stocchero M, Baraldi E et al (2015) Airway metabolic anomalies in adolescents with bronchopulmonary dysplasia: new insights from the metabolomic approach. J Pediatr 166(2):234–239. doi:10.1016/j.jpeds.2014.08.049
Article
CAS
PubMed
Google Scholar
Suursalmi P, Kopeli T, Korhonen P, Lehtimäki L, Nieminen R, Luukkaala T, Moilanen E, Korppi M, Paassilta M, Tammela O et al (2015) Very low birthweight bronchopulmonary dysplasia survivors show no substantial association between lung function and current inflammatory markers. Acta Paediatr 104(3):264–268. doi:10.1111/apa.12837
Article
CAS
PubMed
Google Scholar
Korhonen PH, Suursalmi P, Kopeli T, Nieminen R, Lehtimäki L, Luukkaala T, Korppi M, Saari A, Moilanen E, Tammela OK et al (2015) Inflammatory activity at school age in very low birth weight bronchopulmonary dysplasia survivors. Pediatr Pulmonol 50(7):683–690. doi:10.1002/ppul.23038
Article
PubMed
Google Scholar
McEvoy CT, Jain L, Schmidt B, Abman S, Bancalari E, Aschner JL et al (2014) Bronchopulmonary dysplasia: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases. Ann Am Thorc Soc 11(Suppl 3):S146–S153. doi:10.1513/AnnalsATS.201312-424LD
Article
Google Scholar
Beam KS, Aliaga S, Ahlfeld SK, Cohen-Wolkowiez M, Smith PB, Laughon MM et al (2014) A systematic review of randomized controlled trials for the prevention of bronchopulmonary dysplasia in infants. J Perinatol 34:705–710. doi:10.1038/jp.2014.126
Article
CAS
PubMed
PubMed Central
Google Scholar
Mullassery D, Smith NP (2015) Lung development. Semin Pedaitr Surg 24(4):152–155. doi:10.1053/j.sempedsurg.2015.01.011
Article
Google Scholar
Carraro S, Filippone M, Da Dalt L, Ferraro V, Maretti M, Bressan S, El Mazloum D, Baraldi E et al (2013) Bronchopulmonary dysplasia: the earliest and perhaps the longest lasting obstructive lung disease in humans. Early Hum Dev 2013(89 Suppl 3):S3–S5. doi:10.1016/j.earlhumdev.2013.07.015
Article
Google Scholar
Rossor T, Greenough A (2015) Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia. Exp Rev Respir Med 9(1):35–43. doi:10.1586/17476348.2015.986470
Article
CAS
Google Scholar
Baker CD, Abman SH (2015) Impaired pulmonary vascular development in bronchopulmonary dysplasia. Neonatology 107(4):344–351. doi:10.1159/000381129
Article
PubMed
PubMed Central
Google Scholar
Grover TR, Asikainen TM, Kinsella JP, Abman SH, White CW et al (2007) Hypoxia-inducible factors hif-1alpha and hif-2alpha are decreased in an experimental model of severe respiratory distress syndrome in preterm lambs. Am J Physiol Lung Cell Mol Physiol 292(6):L1345–L1351. doi:10.1152/ajplung.00372.2006
Article
CAS
PubMed
Google Scholar
Miller JD, Benjamin JT, Kelly DR, Frank DB, Prince LS et al (2010) Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines. Am J Physiol Lung Cell Mol Physiol 298(5):L637–L645. doi:10.1152/ajplung.00414.2009
Article
CAS
PubMed
PubMed Central
Google Scholar
Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P et al (2002) Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8(7):702–710. doi:10.1038/nm721
CAS
PubMed
Google Scholar
Hilgendorff A, Parai K, Ertsey R, Navarro E, Jain N, Carandang F, Peterson J, Mokres L, Milla C, Preuss S, Alcazar MA, Khan S, Masumi J, Ferreira-Tojais N, Mujahid S, Starcher B, Rabinovitch M, Bland R et al (2015) Lung matrix and vascular remodeling in mechanically ventilated elastin haploinsufficient newborn mice. Am J Physiol Lung Cell Mol Physiol 308:L464–L478. doi:10.1152/ajplung.00278.2014
Article
CAS
PubMed
Google Scholar
Husain AN, Siddiqui NH, Stocker JT et al (1998) Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29(7):710–717. doi:10.1016/S0046-8177(98)90280-5
Article
CAS
PubMed
Google Scholar
Thibeault DW, Mabry SM, Ekekezie II, Truog WE et al (2000) Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 106(6):1452–1459. doi:10.1542/peds.106.6.1452
Article
CAS
PubMed
Google Scholar
Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, Dixit A et al (2008) Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice: prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 294(1):L3–L14. doi:10.1152/ajplung.00362.2007
Article
CAS
PubMed
Google Scholar
Boström H, Willetts K, Pekny M, Levéen P, Lindahl P, Hedstrand H, Pekna M, Hellström M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Törnell J, Heath JK, Betsholtz C et al (1996) PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85(6):863–873, http://dx.doi.org/10.1016/S0092-8674(00)81270-2
Article
PubMed
Google Scholar
Mokres LM, Parai K, Hilgendorff A, Ertsey R, Alvira CM, Rabinovitch M, Bland RD et al (2010) Prolonged mechanical ventilation with air induces apoptosis and causes failure of alveolar septation and angiogenesis in lungs of newborn mice. Am J Physiol Lung Cell Mol Physiol 298(1):L23–L35. doi:10.1152/ajplung.00251.2009
Article
CAS
PubMed
Google Scholar
Li J, Li Y, He H, Liu C, Li W, Xie L, Zhang Y et al (2016) Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarization. Am J Physiol Lung Cell Mol Physiol. doi:10.1152/s00162.2015
Google Scholar
Malpel S, Mendelsohn C, Cardoso WV et al (2000) Regulation of retinoic acid signaling during lung morphogenesis. Development 127:3057–3067
CAS
PubMed
Google Scholar
Hind M, Corcoran J, Maden M et al (2002) Pre- and Postnatal Lung Development, Maturation, and Plasticity Temporal/spatial expression of retinoid binding proteins and RAR isoforms in the postnatal lung. Am J Physiol Lung Cell Mol Physiol 282:L468–L476. doi:10.1152/ajplung.00196.2001
Article
CAS
PubMed
Google Scholar
Mandell E, Seedorf G, Gien J, Abman SH et al (2014) Vitamin D treatment improves survival and infant lung structure after intra-amniotic endotoxin exposure in rats: potential role for the prevention of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 306:L420–L428. doi:10.1152/ajplung.00344.2013
Article
CAS
PubMed
Google Scholar
Todd DA, Earl M, Lloyd J, Greenberg M, John E et al (1998) Cytological changes in endotracheal aspirates associated with chronic lung disease. Early Hum Dev 51(1):13–22. doi:10.1016/S0378-3782(97)00069-8
Article
CAS
PubMed
Google Scholar
Speer CP (2006) Pulmonary inflammation and bronchopulmonary dysplasia. J Perinatol 26(Suppl1):S57–S62. doi:10.1038/sj.jp.7211476
Article
CAS
PubMed
Google Scholar
Yoon BH, Romero R, Jun JK, Park KH, Park JD, Ghezzi F, Kim BI et al (1997) Amniotic fluid cytokines(interleukin-6,tumornecrosisfactor-alpha,interleukin-1beta,and interleukin-8)and the risk for the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 177:825–830, http://dx.doi.org/10.1016/S0002-9378(97)70276-X
Article
CAS
PubMed
Google Scholar
Zhang ZQ, Huang XM, Lu H et al (2014) Early biomarkers as predictors for bronchopulmonary dysplasia in preterm infants: a systematic review. Eur J Pediatr 173(1):15–23. doi:10.1007/s00431-013-2148-7
Article
CAS
PubMed
Google Scholar
Bhandari V (2014) Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol 100(3):189–201. doi:10.1002/bdra.23220
Article
CAS
PubMed
PubMed Central
Google Scholar
Popova A, Bentley JK, Cui TX, Richardson MN, Lei J, Chen Q et al (2014) Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 307(3):L231–L239. doi:10.1152/ajplung.00342.2013
Article
CAS
PubMed
PubMed Central
Google Scholar
Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalo WM et al (2001) Disrupted Pulmonary Vasculature and Decreased Vascular Endothelial Growth Factor, Flt-1, and TIE-2 in Human Infants Dying with Bronchopulmonary Dysplasia. Am J Respir Crit Care Med 164(10):1971–1980. doi:10.1164/ajrccm.164.10.2101140
Article
CAS
PubMed
Google Scholar
Speer CP (2006) Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 11(5):354–362. doi:10.1016/j.siny.2006.03.004
Article
PubMed
Google Scholar
Toti P, Buonocore G, Tanganelli P, Catella AM, Palmeri ML, Vatti R et al (1997) Bronchopulmonary dysplasia of the premature baby: an immunohistochemical study. Pediatr Pulmonol 24:22–28. doi:10.1002/(SICI)1099-0496(199707)24:1<22::AID-PPUL4>3.0.CO;2-L
Article
CAS
PubMed
Google Scholar
Jonsson B, Li YH, Noack G, Brauner A, Tullus K et al (2000) Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 89:1375–1380. doi:10.1111/j.1651-2227.2000.tb00768.x
Article
CAS
PubMed
Google Scholar
Popova A, Cui TX, Kaciroti N, Goldsmith AM, Linn MJ, Pryhuber GS, Hershenson MB et al (2015) Tracheal aspirate levels of the matricellular protein SPARC predict development of bronchopulmonary dysplasia. PLoS One. doi:10.1371/s0144122
Google Scholar
Popova AP, Bentley JK, Anyanwu AC et al (2012) Glycogen synthase kinase-3β/β-catenin signaling regulates neonatal lung mesenchymal stromal cell myofibroblastic differentiation. Am J Physiol Lung Cell Mol Physiol 303(5):L439–L448. doi:10.1152/ajplung.00408.2011
Article
CAS
PubMed
PubMed Central
Google Scholar
Witsch TJ, Niess G, Sakkas E, Likhoshvay T, Becker S, Herold S, Mayer K, Vadász I, Roberts JD Jr, Seeger W, Morty RE et al (2014) Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J 44:109–121. doi:10.1183/09031936.00075713
Article
CAS
PubMed
PubMed Central
Google Scholar
Witsch TJ, Turowski P, Sakkas E, Niess G, Becker S, Herold S, Mayer K, Vadász I, Roberts JD Jr, Seeger W, Morty RE et al (2014) Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 306(3):L246–L259. doi:10.1152/ajplung.00109.2013
Article
CAS
PubMed
Google Scholar
Prince LR, Maxwell NC, Gill SK, Dockrell DH, Sabroe I, McGreal EP, Kotecha S, Whyte MK et al (2014) Macrophage phenotype is associated with disease severity in preterm infants with chronic lung disease. Plos One 12;9(8):e103059. doi:10.1371/journal.pone.0103059.eCollection2014
Article
Google Scholar
Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD et al (1984) Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130(5):817–821. doi:10.1164/arrd.1984.130.5.817
CAS
PubMed
Google Scholar
Bruce MC, Wedig KE, Jentoft N, Martin RJ, Cheng PW, Boat TF, Fanaroff AA et al (1985) Altered urinary excretion of elastin cross-links in premature infants who develop bronchopulmonary dysplasia. Am Rev Respir Dis 131(4):568–572. doi:10.1164/arrd.1985.131.4.568
CAS
PubMed
Google Scholar
Azizia M, Lloyd J, Allen M, Klein N, Peebles D et al (2012) Immune status in very preterm neonates. Pediatrics 129(4):e967–e974. doi:10.1542/peds.2011-1579d
Article
PubMed
Google Scholar
Kallpur SG, Kramer BW, Knox CL, Berry CA, Collins JJ, Kemp MW, Nitsos I, Polglase GR, Robinson J, Hillman NH, Newnham JP, Chougnet C, Jobe AH et al (2011) Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep. Immunol 187(5):2688–2695. doi:10.4049/jimmunol.1100779
Article
Google Scholar
Lowe J, Watkins WJ, Edwards MO, Spiller OB, Jacqz-Aigrain E, Kotecha SJ, Kotecha S et al (2014) Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. Pediatr Infect Dis J 33:697–702. doi:10.1097/INF.0000000000000239
Article
PubMed
Google Scholar
Hartling L, Liang Y, Lacaze-Masmonteil T et al (2012) Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis. Arch Dis Child Fetal Neonat Ed 97(1):F8–F17. doi:10.1136/adc.2010.210187
Article
Google Scholar
Kuypers E, Collins JJ, Kramer BW, Ofman G, Nitsos I, Pillow JJ, Polglase GR, Kemp MW, Newnham JP, Gavilanes AW, Nowacki R, Ikegami M, Jobe AH, Kallapur SG et al (2012) Intra-amniotic LPS and antenatal betamethasone: inflammation and maturation in preterm lamb lungs. Am J Physiol Lung Cell Mol Physiol 302(4):L380–L389. doi:10.1152/ajplung.00338.2011
Article
CAS
PubMed
Google Scholar
Hartmann WR, Smelter DF, Sathish V, Karass M, Kim S, Aravamudan B, Thompson MA, Amrani Y, Pandya HC, Martin RJ, Prakash YS, Pabelick CM et al (2012) Oxygen dose responsiveness of human fetal airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 303(8):L711–L719. doi:10.1152/ajplung.00037.2012
Article
Google Scholar
Hennrick KT, Keeton AG, Nanua S, Kijek TG, Goldsmith AM, Sajjan US, Bentley JK, Lama VN, Moore BB, Schumacher RE, Thannickal VJ, Hershenson MB et al (2007) Lung Cells from Neonates Show a Mesenchymal Stem Cell Phenotype. Am J Respir Crit Care Med 175(11):1158–1164. doi:10.1164/rccm.200607-941OC
Article
CAS
PubMed
Google Scholar
Blackwell TS, Hipps AN, Yamamoto Y, Han W, Barham WJ, Ostrowski MC, Yull FE, Prince LS et al (2011) NF-kappaB signaling in fetal lung macrophages disrupts airway morphogenesis. J Immunol 187:2740–274. doi:10.4049/jimmunol.1101495
Article
CAS
PubMed
PubMed Central
Google Scholar
Iosef C, Alastalo TP, Hou Y, Chen C, Adams ES, Lyu SC, Cornfield DN, Alvira CM et al (2012) Inhibiting NF-kappaB in the developing lung disrupts angiogenesis and alveolarization. Am J Physiol Lung Cell Mol Physiol 302:L1023–L1036. doi:10.1152/ajplung.00230.2011
Article
CAS
PubMed
PubMed Central
Google Scholar
Hou Y, Liu M, Husted C, Chen C, Thiagarajan K, Johns JL, Rao SP, Alvira CM et al (2015) (2015) Activation of the nuclear factor-kB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2. Am J Physiol Lung Cell Mol Physiol 309:L593–L604. doi:10.1152/ajplung.00029.2015
Article
CAS
PubMed
Google Scholar
McKenna S, Michaelis KA, Agboke F, Liu T, Han K, Yang G, Dennery PA, Wright CJ et al (2014) Sustained hyperoxia-induced NF-kB activation improves survival and preserves lung development in neonatal mice. Am J Phyiol Lung Cell Mol Physiol 306:L1078–L1089. doi:10.1152/ajplung.00001.2014
Article
CAS
Google Scholar
Ehrhardt H, Pritzke Z, Oak P, Kossert M, Biebach L, Förster K, Koschlig M, Alvira CM, Hilgendorff A. Absence of TNF-α enhances inflammatory response in the newborn lung undergoing mechanical ventilation. Am J Physiol Lung Cell Mol Physiol. In press. 2016. doi: 10.1152/ajplung.00367.2015.
Bird AD, McDougall AR, Seow B, Hooper SB, Cole TJ (2015) Glucocorticoid regulation of lung development: lessons learned from conditional GR knockout mice. Mol Endocrinol 29(2):158–171. doi:10.1210/me.2014-1362
Article
PubMed
Google Scholar
Lukkarinen H, Hogmalm A, Lappalainen U, Bry K et al (2009) Matrix metallopro-teinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 41(1):59–68. doi:10.1165/rcmb.2008-0179OC
Article
CAS
PubMed
Google Scholar
Lukkarinen H, Hogmalm A, Lappalainen U, Bry K et al (2009) Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Rspir Crit Care Med 41(1):59–68. doi:10.1165/rcmb.2008-0179OC
CAS
Google Scholar
Gauldie J, Galt T, Bonniaud P, Robbins C, Kelly M, Warburton D et al (2003) Transfer of the active form of transforming growth factor-beta 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am J Pathol 163(6):2575–2584, http://dx.doi.org/10.1016/S0002-9440(10)63612-7
Article
CAS
PubMed
PubMed Central
Google Scholar
Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J et al (2004) Smad3 null mice develop airspace enlargement and are resistant to TGF-betamediated pulmonary fibrosis. J Immunol 173(3):2099–2108. doi:10.4049/jimmunol.173.3.2099
Article
CAS
PubMed
Google Scholar
Wang H, Jafri A, Martin RJ, Nnanabu J, Farver C, Prakash YS, MacFarlane PM et al (2014) Severity of neonatal hyperoxia determines structural and functional changes in developing mouse airway. Am J Physiol Lung Cell Mol Physiol 307(4):L295–L301. doi:10.1152/ajplung.00208.2013
Article
CAS
PubMed
PubMed Central
Google Scholar
Rieger-Fackeldey E, Park MS, Schanbacher BL, Joshi MS, Chicoine LG, Nelin LD, Bauer JA, Welty SE, Smith CV et al (2014) Lung development alterations in newborn mice after recovery from exposure to sublethal hyperoxia. Am J Pathol 184(4):1010–1016. doi:10.1016/j.ajpath.2013.12.021
Article
CAS
PubMed
Google Scholar
Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, Trial Investigators COIN et al (2008) Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 358(7):700–708. doi:10.1056/NEJMoa072788
Article
CAS
PubMed
Google Scholar
Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Donovan EF, Newman NS, Ambalavanan N, Frantz ID 3rd, Buchter S, Sánchez PJ, Kennedy KA, Laroia N, Poindexter BB, Cotten CM, Van Meurs KP, Duara S, Narendran V, Sood BG, O'Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD et al (2010) Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 362(21):1970–1979. doi:10.1056/NEJMoa0911783
Article
CAS
PubMed
Google Scholar
Stevens TP, Finer NN, Carlo WA, Szilagyi PG, Phelps DL, Walsh MC, Gantz MG, Laptook AR, Yoder BA, Faix RG, Newman JE, Das A, Do BT, Schibler K, Rich W, Newman NS, Ehrenkranz RA, Peralta-Carcelen M, Vohr BR, Wilson-Costello DE, Yolton K, Heyne RJ, Evans PW, Vaucher YE, Adams-Chapman I, McGowan EC, Bodnar A, Pappas A, Hintz SR, Acarregui MJ, Fuller J, Goldstein RF, Bauer CR, O'Shea TM, Myers GJ, Higgins RD et al (2014) Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr 165(2):240–249. doi:10.1016/j.jpeds.2014.02.054
Article
PubMed
PubMed Central
Google Scholar
Zivanovic S, Peacock J, Alcazar-Paris M, Lo JW, Lunt A, Marlow N, Calvert S, Greenough A et al (2014) Late outcomes of a randomized trial of high-frequency oscillation in neonates. N Engl J Med 370(12):1121–1130. doi:10.1056/NEJMoa1309220
Article
CAS
PubMed
PubMed Central
Google Scholar
Thome UH, Genzel-Boroviczeny O, Bohnhorst B, Schmid M, Fuchs H, Rohde O, Avenarius S, Topf HG, Zimmermann A, Faas D, Timme K, Kleinlein B, Buxmann H, Schenk W, Segerer H, Teig N, Gebauer C, Hentschel R, Heckmann M, Schlösser R, Peters J, Rossi R, Rascher W, Böttger R, Seidenberg J, Hansen G, Zernickel M, Alzen G, Dreyhaupt J, Muche R, Hummler HD et al (2015) Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial. Lancet Respir Med 3(7):534–543. doi:10.1016/S2213-2600(15)00204-0
Article
PubMed
Google Scholar
Manja V, Lakshminrusimha S, Cook DJ et al (2015) Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis. JAMA Pediatr 169(4):332–340. doi:10.1001/jamapediatrics.2014.3307
Article
PubMed
PubMed Central
Google Scholar
Seger N, Soll R (2009) Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 15(2):CD007836. doi:10.1002/14651858.CD007836
Google Scholar
Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, Siegel J, Avenarius S, von der Wense A, Vochem M, Groneck P, Weller U, Möller J, Härtel C, Haller S, Roth B, Herting E et al (2011) Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet 378(9803):1627–1634. doi:10.1016/S0140-6736(11)60986-0
Article
PubMed
Google Scholar
Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, Teig N, Hoehn T, Böhm W, Welzing L, Vochem M, Hoppenz M, Bührer C, Mehler K, Stützer H, Franklin J, Stöhr A, Herting E, Roth B et al (2015) Nonintubated surfactant application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr 169(8):723–730. doi:10.1001/jamapediatrics.2015.0504
Article
PubMed
Google Scholar
Göpel W, Kribs A, Härtel C, Avenarius S, Teig N, Groneck P, Olbertz D, Roll C, Vochem M, Weller U, von der Wense A, Wieg C, Wintgens J, Preuss M, Ziegler A, Roth B, Herting E, German Neonatal Network (GNN) et al (2015) Less invasive surfactant administration is associated with improved pulmonary outcomes in spontaneously breathing preterm infants. Acta Paediatr 104:241–246. doi:10.1111/apa.12883
Article
PubMed
Google Scholar
Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, Robinson KA, Allen MC et al (2011) Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127(2):e414–e422. doi:10.1542/peds.2010-3428
Article
PubMed
Google Scholar